ARA-290

What it is (in plain language)
- It is a powerful 'rescue' agent for the nervous system. While normal EPO increases blood, ARA-290 ignores blood and focuses only on protecting tissues and nerves against inflammation and cell death. It 'switches off' the chronic inflammatory alarm signal, allowing damaged nerves to begin the regeneration process.

Why do you appear online so much
- It has gained prominence in communities suffering from rare and chronic diseases such as Sarcoidosis and small fibre neuropathy. It is seen as one of the few therapeutic hopes for those suffering from neuropathic pain that does not respond to conventional painkillers.

How it is framed today (pragmatic view)
- 1) Evidence: There are robust clinical trials (Phase II) showing improvement in nerve fibre density and pain reduction. 2) Purpose: Treatment of neuropathies, systemic inflammation and organ protection. 3) Risk: Generally well tolerated; the focus should be on the purity of the compound due to its complex cyclic structure.

How to use this form
- Use the DOI links to access the studies on diabetic neuropathy and sarcoidosis in the database.

- Quick profile (curated by Subject 157)
- Class: Repair
- Status: Verified
- Use case: Repair
- Route: Injectable
- Tags: Injectable|Neuro|Pain
- Half-life: Rapid (<20m)
- Start: Variable
- Duration: ~24 hours

- Mechanism (high level)
Agonist of the innate repair receptor (IRR / EPOR-CD131). Activates anti-inflammatory pathways and nerve repair without stimulating erythropoiesis.

- Evidence (what the literature covers)
RESEARCH RANGE (Clinical, Non-prescriptive):
Clinical trials used 4mg SC daily.
Level of Evidence: A (positive Phase 2 trials).

- Safety and harm-reduction (non-prescriptive)
Risks: No serious adverse effects in trials.
Interactions: Unknown.

- References (anchors)
- Bohr, S. (2013) - ARA-290 reduces neuropathy without erythropoiesis - https://doi.org/10.1073/pnas.1214099110 | PubMed:23479641
- Ahmet, I. (2011) - Helix B surface peptide confers cardioprotection - https://doi.org/10.2119/molmed.2010.00235 | PubMed:21451921

Note: Educational/research content. Does not constitute medical advice, diagnosis or prescription.